PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Podcast: Translationally Enabled Pharma

Pharma 50 Hints to Rest of 2019

The Argument for External Comparator Adoption

Top Story
Pharm Exec's Top 50 Companies 2019
Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market
/Read more/
Advertisement
Deloitte's 2019 Life Sciences accounting and financial reporting update
Insights on new accounting standards and more
A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment.
Download the full report here
ADVERTISEMENT

Pricing
Will Congress Enact Curbs on Drug Pricing?
Congress is weighing in on drug pricing with a range of measures that differ in style and substance. Jill Wechsler reports
/Read more/
Advertisement
LabConnect can't wait for DIA 2019 in lovely San Diego. Come by #823 and see our new booth. We will have a demo of our premium sample tracking software and new innovations to help support your studies. With our worldwide network of leading laboratories and client-inspired services, we can simplify even your most complex clinical trial requirements. We look forward to seeing you!
Learn More
Pricing
Changing the Balance of Negotiation to Impact Drug Prices
In the second in a series of articles summarizing efforts to put each of the "American Patients First" blueprint's four strategies into action, Rick Kelly and Nisha Desai focus on "Better Negotiation"
/Read more/
 
Advertisement
AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
On Demand
Learn More
Medical Affairs
A Blueprint for the Future
Changing customer preferences and a growing need for specialized knowledge are challenging the traditional scope of the medical affairs function. Learn about six ways pharma MA departments can drive more collaborative relationships with caregivers
/Read More/
 
Video
eyeforpharma Philadelphia: Speaker Interviews
Pharm Exec sat down with speakers at this year's eyeforpharma Philadelphia cpnference–including Chris Sellen, Takeda; Gitta Aabo, Greg Apostol, Alkermes; and Amy Nicole Nayer, AbbVie–to get their insights on the hot topics of the moment
/Click here to watch/

Calendar
/ June 23–27: DIA 2019 /
San Diego, CA
/ July 8–9: Leadership for Drug Development Teams /
Boston, MA
/ August 8–9: Direct-to-Patient Clinical Trials /
Philadelphia, PA
/ September 10–11: 5th Annual Bio/Pharmaceutical Product Launch Summit /
Cambridge, MA
/ September 12– 13: 5th Annual Compliance Congress for Specialty Products /
Cambridge, MA
/ September 18–19: 5th Edition Drug Pricing Transparency Congress /
Philadelphia, PA.
/ October 8–9: Life Sciences West Coast Compliance Congress /
San Francisco, CA,
/ November 13–14: 6th Annual Global Compliance Congress /
London, UK
/ December 11: eyeforpharma Awards 2019 /
Philadelphia, PA.

Industry update
//Amicus Therapeutics (Cranbury, NJ) announced two new additions to the senior leadership Team. Jill Weimer, Ph.D., joined as Senior Vice President of Discovery Research and Gene Therapy Science and Simon Jordan, was named Senior Vice President of International. // Altimmune (Gaithersburg, MD) appointed Will Brown as Chief Financial Officer // eGenesis (Cambridge, MA) appointed Ariel Jasie as Chief Business Officer and General Counsel // Agios Pharmaceuticals (Cambridge, MA) announced the planned retirement of its Chief Scientific Officer, Scott Biller, Ph.D. Dr. Biller will retire at the end of 2019 and continue to serve as a strategic advisor through the end of 2020. // RedHill Biopharma (Tel-Aviv, Israel and Raleigh, NC) named Dr. June Almenoff as Chief Scientific Officer.
advertise with us / print subscribe / digital subscribe / visit pharmexec.com